Martin H. Huber Jr. - PRESIDENT AND HEAD OF R&D at Xilio Therapeutics, Inc.

Issuer-level insider activity

Role
President And Head Of R&D
Issuer symbol
XLO on Nasdaq
Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by Martin H. Huber Jr. since 03 Jun 2025

Reported holdings for Martin H. Huber Jr. in Xilio Therapeutics, Inc.

Form 4 holding PRESIDENT AND HEAD OF R&D

Xilio Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
136,500
Estimated value
Report date
16 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Martin H. Huber Jr. in Xilio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .